• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OZZ
Click for more information
0.00% 5.5¢

OZZ RESOURCES LIMITED - News & Media

Market Cap $5.089M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Gold

Ozz Resources Limited is an Australia-based gold and base metal explorer. The Maguires... Ozz Resources Limited is an Australia-based gold and base metal explorer. The Maguires Reward project consists of a single granted prospecting license (P20/2318) covering an area of about 200 hectares (ha). The Pinnacle Well project consists of three exploration licenses (E37/1246, E37/1287 and E37/1355) covering about 150 square kilometers. The project is approximately 10 kilometers (km) east of Mt Davis, about 25 km north of Leonora and adjacent to the Great Northern Highway. The Rabbit Bore project consists of a single exploration license (E51/1671) covering an area of 2,390 ha. The Peterwangy project comprises two granted exploration licenses (E70/5124 and E70/5691) covering 13 blocks for a total area of approximately 4,440 ha. The Vickers Well Project covers two exploration tenement applications, E38/3732 and E38/3733, covering a total area of 251 square kilometers. The Mt Davis project lies adjacent to the Kalgoorlie-Kurnalpi terrane boundary of the Yilgarn Craton.More

No News & Media currently available.

(20min delay)
Last
5.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.089M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
OZZ (ASX) Chart

Top Stories

Firebird achieves preliminary approvals for its Jinshi plant design

Firebird Metals Ltd has reached a significant stage in development of its battery-grade manganese sulphate plant in China
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.